Effect Of high Loading Dose Of Clopidogrel (600mg) Vs Glycoprotein b/a receptor antagonist; tirofiban, in management of patients with non-ST-segment elevation acute coronary syndrome
Mohammed Atef Hamza;
Abstract
Aggressive platelet inhibition is crucial to reduce myocardial injury and early cardiac events after coronary intervention.
Clopidogrel, a potent antiplatelet agent, has become the standard treatment patients with NSTE ACS. The use of a 300-mg loading do
Clopidogrel, a potent antiplatelet agent, has become the standard treatment patients with NSTE ACS. The use of a 300-mg loading do
Other data
| Title | Effect Of high Loading Dose Of Clopidogrel (600mg) Vs Glycoprotein b/a receptor antagonist; tirofiban, in management of patients with non-ST-segment elevation acute coronary syndrome | Other Titles | تأثير الجرعة التحميلية المرتفعة (٦٠٠ ميللي جرام) من عقار كلوبيدوجريل مقابل مضادات مستقبلات الصفائح الدمويـة (٢ب/٣أ) في علاج مرضى القصور الحاد للشرايين التاجية | Authors | Mohammed Atef Hamza | Keywords | Effect Of high Loading Dose Of Clopidogrel (600mg) Vs Glycoprotein b/a receptor antagonist; tirofiban, in management of patients with non-ST-segment elevation acute coronary syndrome | Issue Date | 2010 | Description | Aggressive platelet inhibition is crucial to reduce myocardial injury and early cardiac events after coronary intervention. Clopidogrel, a potent antiplatelet agent, has become the standard treatment patients with NSTE ACS. The use of a 300-mg loading do |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.